Ligand ID: 0HK Drugbank ID: DB01409(Tiotropium) Indication:Used in the management of chronic obstructive pulmonary disease (COPD). |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | THR A 226THR A 225PHE A 223 | 1.80A | 15.72 | None | ||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 5 / 12 | ASP B 936SER B 940THR A 941ALA A 942ASN A1187 | 1.68A | 18.65 | ZN B1301 (-2.4A)NoneNoneNoneNone | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 3 / 3 | ASN C 925LEU B1200PHE C 927 | 0.88A | 14.32 | None | ||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6lzg | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B 442SER B 438TRP B 436ALA B 435TYR B 451 | 1.73A | 18.48 | None | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6lzg | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B 442SER B 438TRP B 436ALA B 435TYR B 451 | 1.66A | 20.52 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6lzg | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B 442SER B 438TRP B 436ALA B 435TYR B 451 | 1.62A | 20.33 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6lzg | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B 442SER B 438TRP B 436ALA B 435TYR B 451 | 1.77A | 22.43 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6lzg | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B 442SER B 438TRP B 436ALA B 435TYR B 451 | 1.56A | 20.33 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | THR A 226THR A 225PHE A 223 | 1.46A | 20.63 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m17 | RECEPTOR BINDINGDOMAIN (SARS-CoV-2) | 5 / 12 | ASP F 398SER F 399THR F 376ALA F 435TYR F 423 | 1.71A | 21.62 | None | ||
![]() | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m17 | RECEPTOR BINDINGDOMAIN (SARS-CoV-2) | 5 / 12 | ASP F 442SER F 438ASN F 440TRP F 436ASN F 343 | 1.58A | 19.70 | NoneNoneNoneNoneNAG F1401 (-2.1A) | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m17 | RECEPTOR BINDINGDOMAIN (SARS-CoV-2) | 5 / 12 | ASP F 442SER F 438ASN F 440TRP F 436ASN F 343 | 1.42A | 19.70 | NoneNoneNoneNoneNAG F1401 (-2.1A) | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | SER A 80THR A 136ALA A 135ALA A 139TYR A 113 | 1.74A | 16.45 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 155PHE B 54TYR B 112 | 1.32A | 16.45 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | THR C 166THR C 167PHE C 172 | 1.02A | 14.07 | None | ||
![]() | 4U14_A_0HKA2000_2 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | ASN A 416LEU A 437PHE A 422TYR A 884 | 1.51A | 20.38 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 862PHE A 422 | 1.53A | 19.98 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 149THR A 123ALA A 185ASN A 215TYR A 69 | 1.79A | 19.98 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 705LEU A 630PHE A 782 | 1.75A | 19.98 | None | ||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 686ALA A 690ALA A 634ASN A 691CYH A 622 | 1.78A | 18.33 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 767LEU A 805PHE A 753 | 1.48A | 19.98 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 437PHE A 422 | 1.18A | 19.98 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 34TYR A 728TYR A 732 | 1.52A | 17.91 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 680TYR A 456ASN A 459TYR A 453CYH A 395 | 1.47A | 19.98 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 215PHE A 192TYR A 237 | 1.28A | 18.33 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 680TYR A 456ASN A 459TYR A 453CYH A 395 | 1.51A | 19.98 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 460PHE A 793 | 1.14A | 19.98 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASP A 454ASN A 459PHE A 165 | 1.22A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 348 | 1.50A | 17.91 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 686ALA A 690ALA A 634ASN A 691CYH A 622 | 1.75A | 18.33 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 862PHE A 422 | 1.43A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 247PHE A 793 | 0.90A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 460PHE A 793 | 1.11A | 17.91 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 348 | 1.48A | 19.98 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP8 (SARS-CoV-2) | 3 / 3 | ASP D 101ASN D 108PHE D 92 | 1.16A | 18.20 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 694 | 1.70A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 3 / 3 | ASN D 104LEU D 91PHE C 49 | 1.72A | 18.20 | None | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 686ALA A 690ALA A 634ASN A 691CYH A 622 | 1.72A | 20.38 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 251PHE A 275 | 1.12A | 19.98 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASP A 761ASN A 691PHE A 480 | 1.78A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 146PHE A 793 | 1.70A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN C 37LEU A 544PHE A 441 | 1.61A | 11.63 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 172PHE A 793 | 0.69A | 17.91 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 636PHE A 348 | 1.73A | 19.98 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | THR A 393THR A 394PHE A 396 | 1.21A | 19.90 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 149THR A 123ALA A 185ASN A 215TYR A 69 | 1.75A | 19.98 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 251PHE A 275 | 0.91A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 791LEU A 131PHE A 793 | 1.61A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 135SER A 784THR A 710ALA A 706TYR A 129 | 1.77A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 838PHE A 422 | 1.53A | 17.91 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 636PHE A 348 | 1.59A | 19.98 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 767LEU A 723PHE A 753 | 1.17A | 19.98 | None | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 149THR A 123ALA A 185ASN A 215TYR A 69 | 1.61A | 20.38 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN C 37LEU C 13PHE A 440 | 1.33A | 10.09 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 437PHE A 422 | 1.13A | 17.91 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 125TYR A 728TYR A 732 | 1.80A | 18.33 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 79PHE A 219TYR A 217 | 1.77A | 18.33 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 3 / 3 | ASN D 104LEU D 91PHE C 49 | 1.56A | 16.31 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416PHE A 422TYR A 884 | 1.33A | 18.33 | None | ||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 623ALA A 449ALA A 554TYR A 453TYR A 456 | 1.70A | 19.90 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 34TYR A 728TYR A 732 | 1.44A | 18.33 | None | ||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 149THR A 123ALA A 185ASN A 215TYR A 69 | 1.64A | 18.33 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 126THR A 189ALA A 185TYR A 217ASN A 215 | 1.57A | 17.91 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 713PHE A 35TYR A 32 | 1.52A | 18.33 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP C1041SER A1030ALA A1022ALA A1025ASN A1023 | 1.62A | 16.69 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 801LEU B 878PHE B 817 | 0.82A | 16.75 | NAG B1309 (-1.8A)NoneNone | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.53A | 18.02 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASP A1139ASN A1119PHE A1103 | 1.42A | 16.75 | NoneNoneNAG A1311 (-4.4A) | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.48A | 17.82 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | THR C 572THR C 573PHE A 43 | 1.16A | 18.15 | None | ||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP C1041SER A1030ALA A1022ALA A1025ASN A1023 | 1.69A | 18.15 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.42A | 18.02 | None | ||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | SER C1030THR C 778ALA C1022ALA C1025ASN C1023 | 1.60A | 16.69 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN A 440PHE A 497TYR A 505 | 1.11A | 16.69 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B 442SER B 438TRP B 436ALA B 435TYR B 451 | 1.78A | 16.75 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vww | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASP A 129ASN A 83PHE A 123 | 0.91A | 20.27 | None | ||
![]() | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP C 796THR B1077THR B1076ASN B1074TYR B 707 | 1.58A | 18.18 | NoneNoneNoneNAG B1316 (-1.9A)None | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ILE C 794ASP C 796THR B1077ASN B1074TYR B 707 | 1.51A | 17.73 | NoneNoneNoneNAG B1316 (-1.9A)None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | SER A1030THR A 778ALA A1022ALA A1025ASN A1023 | 1.63A | 16.71 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP C 442SER C 438TRP C 436ALA C 435TYR C 451 | 1.46A | 18.18 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP C 442SER C 438TRP C 436ALA C 435TYR C 451 | 1.47A | 18.18 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | THR A 393THR A 523PHE A 329 | 1.10A | 18.12 | None | ||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B 442SER B 438TRP B 436ALA B 435TYR B 451 | 1.55A | 18.12 | None | ||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | TYR B 396SER B 514THR B 523ALA B 522TYR C 200 | 1.57A | 16.71 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN A 928LEU A 916PHE A 797 | 1.07A | 18.18 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 801LEU B 878PHE B 817 | 0.71A | 16.64 | NAG B1314 (-1.9A)NoneNone | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASP C1139ASN C1119PHE C1121 | 1.44A | 16.64 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP C 442SER C 438TRP C 436ALA C 435TYR C 451 | 1.60A | 16.64 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 796THR C1077THR C1076ASN C1074TYR C 707 | 1.60A | 18.18 | NoneNoneNoneNAG C1315 (-1.9A)None | ||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | TYR C 396SER C 514THR C 523ALA C 522TYR A 200 | 1.59A | 16.71 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | SER C1030THR C 778ALA C1022ALA C1025ASN C1023 | 1.63A | 16.71 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASP A1139ASN A1119PHE A1121 | 1.44A | 16.64 | None | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | SER C1030THR C 778ALA C1022ALA C1025ASN C1023 | 1.58A | 17.73 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | THR A 393THR A 523PHE A 329 | 1.11A | 18.12 | None | ||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B1041SER C1030ALA C1022ALA C1025ASN C1023 | 1.77A | 18.12 | None | ||
![]() | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 796THR C1077THR C1076ASN C1074TYR C 707 | 1.60A | 18.18 | NoneNoneNoneNAG C1315 (-1.9A)None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN A 801LEU A 878PHE A 817 | 0.72A | 16.64 | NAG A1314 (-1.9A)NoneNone | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 928LEU B 916PHE B 797 | 1.06A | 18.18 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 936SER A 940THR A 723THR A 724ALA A 944 | 1.65A | 16.64 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | THR B 165THR B 166PHE B 171 | 0.92A | 15.17 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN A 154PHE A 53TYR A 111 | 1.36A | 16.88 | MES A 201 (-3.2A)NoneNone | ||
![]() | 4U14_A_0HKA2000_2 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 4 / 4 | ASN B 77LEU A 167PHE A 53TYR A 87 | 1.77A | 15.65 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN D 77LEU C 64PHE C 53 | 1.13A | 15.00 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 77LEU A 64PHE A 53 | 1.19A | 15.00 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 5 / 12 | SER D 79THR D 135ALA D 134ALA D 138TYR D 112 | 1.73A | 16.88 | ZN D 201 ( 4.1A)NoneNoneNoneNone | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN C 154PHE C 53TYR C 111 | 1.36A | 16.88 | MES B 202 (-2.8A)NoneNone | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN D 154PHE D 53TYR D 111 | 1.37A | 16.88 | MES C 204 (-3.2A)NoneNone | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 154PHE B 53TYR B 111 | 1.38A | 16.88 | MES A 203 (-3.1A)NoneNone | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w01 | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN B 278LEU B 255PHE B 280 | 0.91A | 20.27 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w01 | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN A 278LEU A 255PHE A 280 | 1.00A | 21.22 | PEG A 405 (-3.9A)NoneNone | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6w37 | PROTEIN 7A (SARS-CoV-2) | 3 / 3 | THR A 12THR A 13PHE A 44 | 1.75A | 8.38 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6w37 | PROTEIN 7A (SARS-CoV-2) | 3 / 3 | THR A 13THR A 12PHE A 44 | 1.51A | 8.38 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6w37 | PROTEIN 7A (SARS-CoV-2) | 3 / 3 | THR A 13THR A 42PHE A 39 | 1.50A | 8.38 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 12 | ASP C 442SER C 438TRP C 436ALA C 435TYR C 451 | 1.76A | 16.43 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 12 | ASP C 442SER C 438TRP C 436ALA C 435TYR C 451 | 1.61A | 16.42 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 12 | ASP C 442SER C 438TRP C 436ALA C 435TYR C 451 | 1.56A | 16.42 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 3 / 3 | ASN C 370LEU C 387PHE C 374 | 1.72A | 16.42 | None | ||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 12 | ASP C 442SER C 438TRP C 436ALA C 435TYR C 451 | 1.76A | 14.76 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 3 / 3 | THR C 523THR C 393PHE C 515 | 1.47A | 14.76 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w4b | NSP9 (SARS-CoV-2) | 5 / 12 | ASP B 48SER B 47THR B 25ALA B 23ALA B 17 | 1.79A | 14.43 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w4h | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.71A | 20.32 | None | ||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w4h | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.75A | 19.95 | None | ||
![]() | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w4h | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.72A | 20.32 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w4h | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.70A | 20.00 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w4h | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.72A | 20.00 | None | ||
![]() | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.70A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.66A | None | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.68A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.67A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.74A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.70A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.73A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ASP A6900THR A6880ALA A6881ALA A6905CYH B4330 | 1.71A | NoneNoneNoneNone ZN B4403 (-2.3A) | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.69A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ASP A6900THR A6880ALA A6881ALA A6905CYH B4330 | 1.64A | NoneNoneNoneNone ZN B4403 (-2.3A) | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 3 / 3 | ASN B4293LEU A6834PHE B4321 | 1.71A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.65A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.69A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.75A | 16.90 | NoneNoneNoneNoneFMT A7111 ( 4.4A) | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6883PHE C6991 | 1.70A | 19.31 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w75 | NSP10 (SARS-CoV-2) | 5 / 12 | ASP B4317ALA B4307TYR B4379ASN B4367CYH B4356 | 1.79A | 17.00 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6924PHE C6991 | 1.67A | 15.80 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.66A | 15.80 | None | ||
![]() | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.72A | 19.31 | NoneNoneNoneNoneFMT A7111 ( 4.4A) | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.66A | 15.80 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | ASN D4293LEU C6834PHE D4321 | 1.74A | 13.92 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6924PHE C6991 | 1.67A | 19.31 | None | ||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.73A | 16.90 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.67A | 15.80 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.72A | 15.80 | NoneNoneNoneNoneFMT A7111 ( 4.4A) | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.68A | 15.80 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.71A | 19.31 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.66A | 19.31 | None | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.76A | 16.09 | NoneNoneNoneNoneFMT A7111 ( 4.4A) | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | ASN B4293LEU A6834PHE B4321 | 1.69A | 13.92 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6883PHE C6991 | 1.66A | 15.80 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.71A | 19.31 | NoneNoneNoneNoneFMT A7111 ( 4.4A) | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.73A | 16.09 | None | ||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ASP C6900THR C6880ALA C6881ALA C6905CYH D4330 | 1.61A | 16.90 | NoneNoneNoneNone ZN D4401 ( 2.3A) | ||
![]() | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.69A | 19.31 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.69A | 19.31 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.70A | 15.80 | NoneNoneNoneNoneFMT A7111 ( 4.4A) | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 64PHE B 55 | 1.25A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 64PHE B 8 | 1.04A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN C 13LEU C 64PHE C 8 | 1.14A | None | |||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ASP B 134ALA B 153ALA B 149TYR B 72TYR B 71 | 1.77A | 17.94 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN C 13LEU C 64PHE C 8 | 0.93A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ILE C 14THR C 90ALA C 145ALA C 139TYR C 56 | 1.75A | None | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN A 13PHE A 55TYR A 35 | 1.61A | 21.86 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 64PHE B 55 | 1.34A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN C 13LEU C 80PHE C 55 | 1.43A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 87PHE B 55 | 1.12A | None | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN C 13PHE C 55TYR C 35 | 1.51A | 21.86 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | THR B 311THR B 312PHE B 216 | 1.78A | 17.94 | None | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | TYR B 273THR B 168ALA B 116ALA B 114CYH B 260 | 1.73A | NoneNoneNone CL B 502 ( 3.8A)None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN C 13LEU C 80PHE C 55 | 1.27A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 36PHE A 8 | 1.43A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 64PHE A 8 | 0.73A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | TYR C 273THR C 168ALA C 116ALA C 114CYH C 260 | 1.77A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | THR C 311THR C 312PHE C 216 | 1.78A | 17.94 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 64PHE A 8 | 0.90A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 80PHE B 55 | 1.37A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN C 13LEU C 64PHE C 55 | 1.32A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ASP A 134ALA A 153ALA A 149TYR A 72TYR A 71 | 1.76A | None | |||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ASP C 134ALA C 153ALA C 149TYR C 72TYR C 71 | 1.77A | 17.94 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 64PHE A 55 | 1.21A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ASP C 134ALA C 153ALA C 149TYR C 72TYR C 71 | 1.71A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 87PHE B 55 | 1.44A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ASP B 134ALA B 153ALA B 149TYR B 72TYR B 71 | 1.70A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 36PHE B 8 | 1.30A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 64PHE B 8 | 0.86A | None | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13PHE B 55TYR B 35 | 1.43A | 21.86 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 36PHE B 8 | 1.35A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | SER C 170THR C 115THR C 119ALA C 116CYH C 155 | 1.66A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | SER A 170THR A 115THR A 119ALA A 116CYH A 155 | 1.65A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN B 13LEU B 80PHE B 55 | 1.08A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | SER C 170THR C 115THR C 119ALA C 116CYH C 155 | 1.77A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN C 13LEU C 64PHE C 55 | 1.28A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 64PHE A 55 | 1.28A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ILE A 14THR A 90ALA A 145ALA A 139TYR A 56 | 1.68A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | SER B 170THR B 115THR B 119ALA B 116CYH B 155 | 1.80A | None CL B 502 ( 4.9A)NoneNoneNone | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wcf | NSP3 (SARS-CoV-2) | 3 / 3 | ASN A 150LEU A 12PHE A 6 | 1.53A | None | |||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP A 288ASN A 354PHE A 307 | 1.78A | 18.36 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP D 288ASN D 285PHE D 274 | 1.58A | 18.36 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 285LEU B 291PHE A 314 | 1.55A | None | |||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP C 288ASN C 285PHE C 274 | 1.56A | 18.36 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP F 288ASN F 354PHE F 307 | 1.79A | 18.36 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP B 288ASN B 285PHE B 274 | 1.58A | 18.36 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP F 288ASN F 285PHE F 274 | 1.58A | 18.36 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP A 288ASN A 285PHE A 274 | 1.55A | 18.36 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP E 288ASN E 285PHE E 274 | 1.59A | 18.36 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP C 288ASN C 354PHE C 307 | 1.77A | 18.36 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASN F 285LEU F 291PHE E 314 | 1.58A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | THR C 263THR C 296PHE D 315 | 1.51A | 15.30 | None | ||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ILE B 320TYR B 333SER B 318ALA A 311ALA B 308 | 1.77A | NoneNoneNone CL B 401 ( 3.7A)None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.66A | FMT A7107 (-3.7A)NoneNone | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6883PHE C6991 | 1.66A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6924PHE C6991 | 1.66A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6924PHE C6991 | 1.67A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.66A | FMT A7107 (-3.7A)NoneNone | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ASP C6900THR C6880ALA C6881ALA C6905CYH D4330 | 1.65A | NoneNoneNoneNone ZN D4401 (-2.3A) | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.69A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TRP C7029THR C6993ALA C7002ALA C6990CYH C6823 | 1.79A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.69A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.65A | FMT A7107 (-3.7A)NoneNone | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.67A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.74A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.74A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.76A | NoneNoneNoneNoneFMT A7105 (-4.3A) | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.74A | NoneNoneNoneNoneFMT A7105 (-4.3A) | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.70A | NoneNoneNoneNoneFMT A7105 (-4.3A) | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.70A | NoneNoneNoneNoneFMT A7105 (-4.3A) | |||
![]() | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.70A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6883PHE C6991 | 1.70A | None | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wjt | NSP10 (SARS-CoV-2) | 5 / 12 | ASP B4317ALA B4307TYR B4379ASN B4367CYH B4356 | 1.78A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 3 / 3 | ASN B4293LEU A6834PHE B4321 | 1.72A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.71A | FMT A7107 (-3.7A)NoneNone | |||
![]() | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.71A | NoneNoneNoneNoneFMT A7105 (-4.3A) | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.71A | NoneNoneNoneNoneFMT A7105 (-4.3A) | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | THR A 165THR A 166PHE A 171 | 1.25A | 14.32 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | THR C 166THR C 165PHE C 171 | 1.67A | 14.32 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | SER C 79THR C 135ALA C 134ALA C 138TYR C 112 | 1.73A | ZN C 201 (-3.5A)NoneNoneNoneNone | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | SER D 79THR D 135ALA D 134ALA D 138TYR D 112 | 1.69A | ZN D 202 ( 4.1A)NoneNoneNoneNone | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | THR B 165THR B 166PHE B 171 | 1.24A | 14.32 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | SER A 79THR A 135ALA A 134ALA A 138TYR A 112 | 1.75A | ZN A 201 (-3.3A)NoneNoneNoneNone | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | THR C 165THR C 166PHE C 171 | 1.25A | 14.32 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASN C 154PHE C 53TYR C 111 | 1.52A | 17.50 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASN D 154PHE D 53TYR D 111 | 1.31A | 17.50 | MES D 201 (-3.8A)NoneNone | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | THR D 165THR D 166PHE D 171 | 1.20A | 14.32 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 77LEU A 64PHE A 53 | 1.38A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 77LEU A 64PHE A 53 | 1.20A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | SER B 79THR B 135ALA B 134ALA B 138TYR B 112 | 1.71A | ZN B 202 (-3.2A)NoneNoneNoneNone | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 154PHE B 53TYR B 111 | 1.39A | 17.50 | MES B 201 (-3.2A)NoneNone | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASN D 77LEU C 64PHE C 53 | 1.28A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.68A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6883PHE C6991 | 1.66A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.73A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.66A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6883PHE C6991 | 1.70A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.71A | NoneNoneNoneNoneFMT A7107 ( 4.3A) | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.66A | None | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.66A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6924PHE C6991 | 1.66A | None | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkq | NSP10 (SARS-CoV-2) | 5 / 12 | ASP B4317ALA B4307TYR B4379ASN B4367CYH B4356 | 1.78A | None | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.70A | NoneNoneNoneNoneFMT A7107 ( 4.3A) | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.70A | NoneNoneNoneNoneFMT A7107 ( 4.3A) | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.68A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | ASN B4293LEU A6834PHE B4321 | 1.71A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.66A | None | |||
![]() | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.71A | NoneNoneNoneNoneFMT A7107 ( 4.3A) | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.73A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ASP C6900THR C6880ALA C6881ALA C6905CYH D4330 | 1.61A | NoneNoneNoneNone ZN D4401 ( 2.3A) | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.76A | NoneNoneNoneNoneFMT A7107 ( 4.3A) | |||
![]() | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR C7026TRP C7029THR C6993ALA C6808TRP C6988 | 1.69A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.74A | NoneNoneNoneNoneFMT A7107 ( 4.3A) | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | ASN C6853LEU C6924PHE C6991 | 1.67A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.71A | None | |||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASP A 129ASN A 83PHE A 123 | 0.97A | 20.59 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASP B 129ASN B 83PHE B 123 | 0.94A | 20.59 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN B 278LEU B 255PHE B 280 | 1.13A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN B 12LEU B 43PHE B 16 | 1.53A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN B 140LEU B 190PHE B 124 | 1.59A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN A 278LEU A 255PHE A 280 | 0.99A | 20.32 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN A 140LEU A 190PHE A 124 | 1.61A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN A 278LEU A 255PHE A 280 | 1.12A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN B 278LEU B 249PHE B 280 | 1.70A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN A 12LEU A 43PHE A 16 | 1.53A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASN B 278LEU B 255PHE B 280 | 0.97A | 20.32 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASP A 324ASN A 74PHE A 123 | 1.45A | 20.59 | NoneEDO A 406 (-4.5A)None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASP B 324ASN B 74PHE B 123 | 1.46A | 20.59 | None | ||
![]() | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.69A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ASP A6900THR A6880ALA A6881ALA A6905CYH B4330 | 1.63A | NoneNoneNoneNone ZN B4401 (-2.3A) | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.68A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.69A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.66A | None | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.67A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.66A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wq3 | NSP10 (SARS-CoV-2) | 3 / 3 | ASN B4358LEU B4284PHE B4363 | 1.36A | SO4 A7107 (-4.0A)NoneNone | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.74A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6924PHE A6991 | 1.67A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | ASN A6853LEU A6883PHE A6991 | 1.69A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A7026TRP A7029THR A6993ALA A6808TRP A6988 | 1.73A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 3 / 3 | ASN D 104LEU C 60PHE C 49 | 1.63A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 3 / 3 | ASN D 104LEU D 91PHE C 49 | 1.65A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | ASP A 134ALA A 153ALA A 149TYR A 72TYR A 71 | 1.73A | None | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | ASN A 13PHE A 55TYR A 35 | 1.59A | 21.99 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | SER A 170THR A 115THR A 119ALA A 116CYH A 155 | 1.69A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 36PHE A 8 | 1.43A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | SER A 170THR A 115THR A 119ALA A 116CYH A 155 | 1.74A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 64PHE A 8 | 0.89A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 64PHE A 8 | 0.88A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 64PHE A 55 | 1.22A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | THR A 311THR A 312PHE A 216 | 1.79A | 20.55 | None | ||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | ASP A 134ALA A 153ALA A 149TYR A 72TYR A 71 | 1.79A | 20.55 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | ASN A 13LEU A 64PHE A 55 | 1.24A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | ILE A 300ASP A 302SER A 262ALA A 114CYH A 260 | 1.62A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6wrh | NSP3 (SARS-CoV-2) | 3 / 3 | ASN A 308LEU A 234PHE A 241 | 0.93A | 21.32 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6xdc | PROTEIN 3A (SARS-CoV-2) | 3 / 3 | ASN A 82LEU B 53PHE A 87 | 1.07A | 21.29 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6xdc | PROTEIN 3A (SARS-CoV-2) | 3 / 3 | ASN B 82LEU A 53PHE B 87 | 1.14A | 21.29 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6xdc | PROTEIN 3A (SARS-CoV-2) | 3 / 3 | ASN A 82LEU B 53PHE A 56 | 1.30A | 21.29 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6xdc | PROTEIN 3A (SARS-CoV-2) | 3 / 3 | ASN B 82LEU A 53PHE B 56 | 1.37A | 21.29 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6xez | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 251PHE A 275 | 0.88A | 17.36 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6xez | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 247PHE A 793 | 1.05A | 17.36 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6xez | NSP13 (SARS-CoV-2) | 3 / 3 | ASN F 381PHE F 422TYR F 421 | 1.47A | 21.13 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | THR A 196THR A 198PHE A 134 | 1.64A | 15.72 | DMS A 404 (-4.8A)DMS A 404 (-3.8A)None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 3 / 3 | ASP B 101ASN B 108PHE B 92 | 1.57A | 17.75 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | THR A 125THR A 126PHE A 131 | 1.01A | 13.56 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | THR E 523THR E 393PHE E 515 | 1.68A | 17.14 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN E 388LEU E 335PHE E 392 | 1.73A | None | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.65A | NoneNoneDMS A 901 (-3.5A)NoneNone | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.58A | NoneNoneDMS A 901 (-3.5A)NoneNone | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.78A | NoneNoneDMS A 901 (-3.5A)NoneNone | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.63A | NoneNoneDMS E 901 ( 3.9A)NoneNone | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN E 388LEU E 335PHE E 392 | 1.77A | None | |||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.75A | 17.14 | NoneNoneDMS A 901 (-3.5A)NoneNone | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.77A | NoneNoneDMS E 901 ( 3.9A)NoneNone | |||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.75A | 17.14 | NoneNoneDMS E 901 ( 3.9A)NoneNone | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.57A | NoneNoneDMS E 901 ( 3.9A)NoneNone | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.79A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.55A | None | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.61A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN E 388LEU E 335PHE E 392 | 1.79A | None | |||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.74A | 17.14 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | THR E 523THR E 393PHE E 515 | 1.67A | 17.14 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.76A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.65A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | THR A 26THR A 25PHE A 66 | 1.79A | 20.55 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | THR A 24THR A 25PHE A 66 | 1.62A | 20.55 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | THR A 25THR A 26PHE A 66 | 1.50A | 20.55 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN E 388LEU E 335PHE E 392 | 1.73A | None | |||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.74A | 18.72 | None | ||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.57A | None | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.76A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.56A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.80A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN A 388LEU A 335PHE A 392 | 1.76A | None | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.77A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN A 388LEU A 335PHE A 392 | 1.72A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | THR A 523THR A 393PHE A 515 | 1.68A | 18.72 | None | ||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.75A | 18.72 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | THR E 523THR E 393PHE E 515 | 1.68A | 18.72 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 442SER A 438TRP A 436ALA A 435TYR A 451 | 1.63A | None | |||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP E 442SER E 438TRP E 436ALA E 435TYR E 451 | 1.62A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN E 388LEU E 335PHE E 392 | 1.77A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 3 / 3 | ASN C 150LEU C 12PHE C 6 | 1.51A | EDO C 204 ( 4.5A)NoneNone | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 3 / 3 | ASN B 59LEU E 164PHE E 156 | 1.27A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6zsl | SARS-COV-2 HELICASENSP13 (SARS-CoV-2) | 3 / 3 | ASN A 9LEU A 130PHE A 24 | 1.33A | 23.06 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6zsl | SARS-COV-2 HELICASENSP13 (SARS-CoV-2) | 3 / 3 | ASN B 489LEU B 526PHE B 546 | 0.99A | 23.06 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6zsl | SARS-COV-2 HELICASENSP13 (SARS-CoV-2) | 3 / 3 | ASN A 489LEU A 526PHE A 546 | 0.94A | 23.06 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 6zsl | SARS-COV-2 HELICASENSP13 (SARS-CoV-2) | 3 / 3 | ASN A 9LEU A 132PHE A 24 | 1.34A | 23.06 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | THR A 226THR A 225PHE A 223 | 1.66A | 20.55 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 657LEU A 372PHE A 528 | 1.35A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 247PHE A 793 | 1.44A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 348 | 1.48A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | THR A 393THR A 394PHE A 396 | 1.13A | 19.90 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASP A 761ASN A 691PHE A 480 | 1.78A | 17.91 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 460PHE A 793 | 1.09A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 460PHE A 793 | 1.09A | None | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 713PHE A 35TYR A 32 | 1.48A | 18.33 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 636PHE A 694 | 1.75A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 767LEU A 805PHE A 753 | 1.50A | None | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 79PHE A 219TYR A 217 | 1.71A | 18.33 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 791LEU A 131PHE A 793 | 1.60A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 251PHE A 275 | 0.90A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 623ALA A 449ALA A 448TYR A 453TYR A 456 | 1.79A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 146PHE A 793 | 1.71A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 34TYR A 728TYR A 732 | 1.44A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP7NSP8 (SARS-CoV-2) | 3 / 3 | ASN D 104LEU D 91PHE C 49 | 1.66A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 862PHE A 422 | 1.72A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 437PHE A 422 | 1.20A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 39LEU A 708PHE A 35 | 1.25A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 247PHE A 793 | 0.95A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 251PHE A 275 | 1.02A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 7btf | NSP12NSP8 (SARS-CoV-2) | 3 / 3 | THR B 89THR B 93PHE A 340 | 1.67A | 15.73 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP8 (SARS-CoV-2) | 3 / 3 | ASP D 134ASN D 140PHE D 147 | 1.58A | 18.20 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 767LEU A 723PHE A 753 | 1.16A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 694 | 1.62A | None | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 126THR A 189ALA A 185TYR A 217ASN A 215 | 1.54A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 695LEU A 749PHE A 480 | 1.76A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 348 | 1.47A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN A 552LEU C 35PHE A 440 | 1.76A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 172PHE A 793 | 0.80A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 125TYR A 728TYR A 732 | 1.76A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | THR A 929THR A 926PHE A 594 | 1.42A | 19.90 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 437PHE A 422 | 1.22A | None | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 34TYR A 728TYR A 732 | 1.53A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 862PHE A 422 | 1.58A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7btf | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN C 37LEU A 544PHE A 441 | 1.65A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 636PHE A 348 | 1.62A | None | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 215PHE A 192TYR A 237 | 1.35A | 18.33 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 623ALA A 449ALA A 554TYR A 453TYR A 456 | 1.71A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 694 | 1.72A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP7NSP8 (SARS-CoV-2) | 3 / 3 | ASN D 104LEU C 60PHE C 49 | 1.64A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 636PHE A 348 | 1.75A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | ASN A 221LEU A 262PHE A 219 | 1.75A | None | |||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASP A 454ASN A 459PHE A 165 | 1.29A | 17.75 | None | ||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 34TYR A 728TYR A 732 | 1.58A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 694 | 1.72A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ILE D 120SER C 54THR C 9ALA C 48ASN D 100 | 1.78A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 247PHE A 793 | 0.95A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 767LEU A 723PHE A 753 | 1.14A | None | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 215PHE A 192TYR A 237 | 1.28A | 18.40 | None | ||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 3 / 3 | THR B 89THR B 93PHE A 340 | 1.73A | 16.86 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 437PHE A 422 | 1.15A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 3 / 3 | ASN D 104LEU D 91PHE C 49 | 1.64A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 862PHE A 422 | 1.54A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 251PHE A 275 | 1.14A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 34TYR A 728TYR A 732 | 1.51A | None | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 135SER A 784THR A 710ALA A 706TYR A 129 | 1.71A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 247PHE A 793 | 1.49A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 460PHE A 793 | 1.18A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 348 | 1.51A | None | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 126THR A 189ALA A 185TYR A 217ASN A 215 | 1.60A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 135SER A 784THR A 710ALA A 706TYR A 129 | 1.67A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 862PHE A 422 | 1.67A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN A 552LEU C 35PHE A 440 | 1.49A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 126THR A 189ALA A 185TYR A 217ASN A 215 | 1.59A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 791LEU A 131PHE A 793 | 1.55A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 767LEU A 805PHE A 753 | 1.54A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 623ALA A 449ALA A 554TYR A 453TYR A 456 | 1.64A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | THR A 393THR A 394PHE A 396 | 1.07A | 19.52 | None | ||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 623ALA A 449ALA A 554TYR A 453TYR A 456 | 1.62A | 19.52 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN C 37LEU C 13PHE A 440 | 1.37A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 636PHE A 694 | 1.75A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 348 | 1.52A | None | |||
![]() | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 686ALA A 690ALA A 634ASN A 691CYH A 622 | 1.79A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN A 552LEU C 35PHE A 440 | 1.59A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN C 37LEU A 544PHE A 441 | 1.76A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 705LEU A 630PHE A 471 | 0.95A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 437PHE A 422 | 1.16A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 657LEU A 372PHE A 528 | 1.47A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 135SER A 784THR A 710ALA A 706TYR A 129 | 1.72A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 460PHE A 793 | 1.18A | None | |||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv1 | NSP8 (SARS-CoV-2) | 3 / 3 | ASN B 140PHE B 147TYR B 149 | 1.66A | 19.62 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 125TYR A 728TYR A 732 | 1.79A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 705LEU A 630PHE A 471 | 1.02A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 172PHE A 793 | 0.90A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 251PHE A 275 | 0.95A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 694 | 1.62A | None | |||
![]() | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | SER A 343ALA A 656ALA A 660TYR A 653ASN A 657 | 1.73A | 19.52 | None | ||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 623ALA A 449ALA A 554TYR A 453TYR A 456 | 1.68A | POP A1003 ( 3.5A)NoneNoneNoneNone | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 437PHE A 422 | 1.15A | None | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 34TYR A 728TYR A 732 | 1.53A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 247PHE A 793 | 1.48A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 791LEU A 131PHE A 793 | 1.58A | None | |||
![]() | 5CXV_A_0HKA501_2 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | THR A 393THR A 394PHE A 396 | 1.16A | 19.52 | None | ||
![]() | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 215PHE A 192TYR A 237 | 1.39A | 18.40 | None | ||
![]() | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 680TYR A 456ASN A 459TYR A 453CYH A 395 | 1.57A | F86 P 102 ( 4.9A)NoneNoneNoneNone | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 657LEU A 372PHE A 528 | 1.39A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 125TYR A 728TYR A 732 | 1.74A | None | |||
![]() | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 126THR A 189ALA A 185TYR A 217ASN A 215 | 1.55A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 705LEU A 630PHE A 471 | 0.91A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 767LEU A 723PHE A 753 | 1.13A | None | |||
![]() | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | SER A 759ALA A 634ALA A 690TYR A 619CYH A 622 | 1.79A | U P 20 ( 2.8A)NoneNoneNoneF86 P 102 ( 4.6A) | |||
![]() | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 126THR A 189ALA A 185TYR A 217ASN A 215 | 1.55A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 172PHE A 793 | 0.76A | 17.75 | None | ||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASP A 608ASN A 611PHE A 766 | 1.76A | 17.75 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 348 | 1.51A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 251PHE A 275 | 0.94A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 314LEU A 251PHE A 275 | 1.10A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 348 | 1.52A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 460PHE A 793 | 1.18A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 469PHE A 782 | 1.75A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 694 | 1.64A | None | |||
![]() | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASP A 454ASN A 459PHE A 165 | 1.28A | 17.75 | None | ||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 168LEU A 460PHE A 793 | 1.18A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | SER A 343ALA A 656ALA A 660TYR A 653ASN A 657 | 1.68A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 705LEU A 630PHE A 471 | 0.89A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN C 37LEU C 13PHE A 440 | 1.39A | None | |||
![]() | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 465THR A 206ALA A 34TYR A 728TYR A 732 | 1.42A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN A 552LEU C 35PHE A 440 | 1.55A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 862PHE A 422 | 1.66A | None U P 17 ( 4.9A)None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 636PHE A 694 | 1.75A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 767LEU A 805PHE A 753 | 1.54A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN A 552LEU C 35PHE A 440 | 1.56A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 416LEU A 437PHE A 422 | 1.12A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN C 37LEU A 544PHE A 441 | 1.77A | None | |||
![]() | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 628LEU A 308PHE A 694 | 1.75A | None | |||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ASN A 790LEU A 247PHE A 793 | 0.88A | 17.75 | None | ||
![]() | 5DSG_A_0HKA1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 3 / 3 | ASN C 37LEU C 55PHE A 440 | 1.31A | None |